FDA says Bristol-Myers diabetes drug appears to meet standards for heart safety

WASHINGTON - Federal health officials in the United States said Monday a potential blockbuster diabetes medication from Bristol-Myers Squibb appears free from heart-related side effects that have plagued similar treatments....More